Reference and how-to content for starting, managing, and understanding GLP-1 treatment.
10 articles.
Choose the question you want to answer first.
Monthly prices, upfront payments and plan terms.
PillsOral options, formulations and the differences to check.
MedicationsUnderstand the medications before comparing programs.
CoverageCoverage paths, program conditions and next steps.
A Spanish website does not guarantee Spanish care. Compare published language support for consultations, written instructions, billing and pharmacy questions before paying.
October 8, 2026
6 min read
GLP-1 treatment may qualify for HSA or FSA payment, but a card logo is not approval of every charge. Check the prescription, invoice, account rules and timing before paying.
October 5, 2026
6 min read
To switch GLP-1 providers, have the new clinician review your care and confirm the prescription and pharmacy before you cancel the old plan. Three programs, Collective, Embody and TrimRx, say in public that their prescriber can continue your current dose if a clinician approves. Your dose, supply and prepaid balance do not carry over automatically.
September 19, 2026
8 min read
Neither the Wegovy nor the Zepbound prescribing information mentions alcohol. This is what the labels do say about hypoglycemia and nausea, what the craving research has and has not shown, and what changes if you also take insulin or a sulfonylurea.
August 2, 2026
9 min read
What the Ozempic, Wegovy, Mounjaro and Zepbound labels actually say about the fridge, the counter, a hot car, a freezer, and an airport checkpoint. Each answer is in the first sentence, because you are probably reading this in a hurry.
August 2, 2026
9 min read
Yes for Wegovy and the Zepbound KwikPen, if you qualify: the Medicare GLP-1 Bridge covers them for weight management at $50 a month. Ozempic is not in the Bridge, and basic Part D does not pay for it solely for weight loss. Check the exact drug, form and reason it is prescribed before you pay.
July 6, 2026
8 min read
Ozempic is not FDA-approved for PCOS. It is approved for type 2 diabetes. The 2023 international PCOS guideline says semaglutide may be considered, alongside active lifestyle intervention, for weight management in adults with PCOS and higher weight under general-population criteria. That is different from an approval to treat PCOS or infertility. Coverage depends on the prescribed product, approved indication, plan formulary and prior-authorization rules. This guide separates the evidence from the labels, then compares realistic coverage and cash-pay paths.
June 24, 2026
11 min read
Five GLP-1 medicines are FDA-approved for weight loss: Wegovy injection, the Wegovy pill, Zepbound, Foundayo and Saxenda. You generally qualify with a BMI of 30 or more, or 27 or more with a weight-related condition. In trials, Wegovy injections averaged 14.9% weight loss and Zepbound up to 20.9%. Here is who qualifies, what each option costs and how to get a prescription.
April 13, 2026
12 min read
Greasy meals can be harder to tolerate on a GLP-1, but there is no list of banned foods. Smaller, slower, lower-fat meals may help with nausea. Here is what to change for each symptom, and when to call your clinician instead.
April 11, 2026
5 min read
Small meal changes may help mild nausea, but persistent symptoms need your prescriber. A practical checklist for symptoms, hydration, dose questions and warning signs.
April 11, 2026
8 min read
Ready to choose a program? Take the 60-second match quiz or see our top-ranked GLP-1 providers.
Affiliate partners we feature. We may earn a commission.
Check the medication, commitment and total price for your selected plan.
Affiliate links, we earn a commission at no extra cost to you. These are featured partners, prioritized by our affiliate economics, not an editorial "best" ranking. Published scores have different evidence limits and do not establish better care. See the program comparison and scoring limitations.